Stimulation of cardiac receptors with veratrum alkaloids inhibits ADH secretion.
The purpose of this study was to determine whether cardiac receptors that are stimulated by veratrum alkaloids exert an inhibitory influence on the secretion of vasopressin (ADH). In six chloralose-anesthetized dogs, injection of cryptenamine (2 microgram/kg) into the circumflex coronary artery resulted in a significant (P < 0.05) fall in arterial pressure (-45 +/- 5 mmHg). Despite this hypotension and the presence of intact arterial baroreflexes, there was no change in plasma ADH (measured in the superior vena cava). In eight dogs with sinoaortic baroreceptor denervation, hemorrhage of 10 ml/kg decreased arterial pressure 20 +/- 5 mmHg (P < 0.05) and increased plasma ADH from 14 +/- 5 to 38 +/- 13 microU/ml (P < 0.05). Intracoronary injection of cryptenamine (1 microgram/kg) decreased plasma ADH to 23 +/- 7 microU/ml during the 5 min immediately after cryptenamine injection and to 16 +/- 4 microU/ml 20 min after injection. In eight dogs with sinoaortic denervation, hemorrhage and injection of vehicle resulted in a progressive increase in plasma ADH over the same time period. Vagotomy abolished the inhibitory response to cryptenamine injection. These data show that stimulation of cardiac receptors with vagal afferents by intracoronary injection of a veratrum alkaloid inhibits ADH secretion. Activation of these receptors can prevent arterial baroreflex-induced increases in ADH.
D000344:Afferent Pathways / Q000187:drug effects; D000818:Animals; D003714:Denervation; D004285:Dogs; D006325:Heart Atria / Q000294:innervation*; D006352:Heart Ventricles / Q000294:innervation*; D008297:Male; D011311:Pressoreceptors / Q000187:drug effects*; D011526:Protoveratrines / Q000494:pharmacology; D014630:Vagus Nerve / Q000187:drug effects; D014667:Vasopressins / Q000378:metabolism*; D014704:Veratrum Alkaloids / Q000494:pharmacology*
D011526:Protoveratrines; D014704:Veratrum Alkaloids; D014667:Vasopressins